Unknown

Dataset Information

0

Long-term oncologic outcomes of breast conserving surgery with propofol-based total intravenous anesthesia or volatile inhalational general anesthesia without propofol: a propensity score-matched, population-based cohort study


ABSTRACT: To estimate oncologic outcomes (overall survival [OS], locoregional recurrence [LRR], and distant metastasis [DM]) in patients with breast intraductal carcinoma (IDC) receiving breast conserving surgery (BCS) under propofol-based total intravenous anesthesia (TIVA) or volatile inhalational (INHA) general anesthesia (GA) without propofol. Patients with breast IDC receiving BCS were recruited through propensity score matching and categorized by anesthesia techniques into propofol-based TIVA-GA and non-propofol-based INHA-GA groups, respectively. Cox regression analysis was performed to calculate hazard ratios and 95% confidence intervals (CIs). In multivariate Cox regression analysis, the adjusted hazard ratio (aHR; 95% CI) of all-cause mortality for TIVA-GA with propofol compared with INHA-GA without propofol was 0.94 (0.83-1.31). The aHR (95% CI) of LRR for TIVA-GA with propofol group compared with INHA-GA without propofol was 0.77 (0.58-0.87). The aHR (95% CI) of DM for TIVA-GA with propofol compared with INHA-GA without propofol was 0.91 (0.82-1.24). Propofol-based TIVA-GA might be beneficial for reducing LRR in women with breast IDC receiving BCS compared with non-propofol-based INHA-GA.

SUBMITTER: Zhang J 

PROVIDER: S-EPMC8569355 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8159053 | biostudies-literature
| S-EPMC10834723 | biostudies-literature
| S-EPMC6028176 | biostudies-literature
| S-EPMC9832634 | biostudies-literature
| S-EPMC7241788 | biostudies-literature
| S-EPMC8341516 | biostudies-literature
| S-EPMC6837387 | biostudies-literature
| S-EPMC7077845 | biostudies-literature
| S-EPMC10769032 | biostudies-literature
| S-EPMC10111921 | biostudies-literature